Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children				Phase III, Phase II				EUDRACT 2005-002618-40 BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723
	Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors				Phase III				CHLA-HEAD-START-III CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
	SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours				Phase III				SCRT Trial NCT00517959
	Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy				Phase III				CCLG-CNS-2007-09 CCLG CNS 2007 09, EU-20835, NCT00683319
	A Phase I/II Study of the Photon Radiosurgery System				Phase II, Phase I				CNS 0201 NCT00179907
	Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors				Phase II, Phase I				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
	A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors				Phase II, Phase I				SUN08-01 NCT00704054
	Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors				Phase II, Phase I				CHNMC-07053 07053, CA180 121, NCT00788125
	Antineoplaston Therapy in Treating Children With Brain Tumors				Phase II				BC-BT-10 NCT00003458
	Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors				Phase II				BC-BT-22 NCT00003476


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute